Balaji Amines Limited Q2 Revenue Reaches ₹4.68 Billion, Up 37.65%

Balaji Amines Limited reported consolidated revenue from operations of ₹4.68 billion for Q2 FY27, compared with ₹3.40 billion in the year-ago period, representing 37.65% growth. The company also recorded consolidated profit after tax of ₹0.67 billion for the quarter ended September 30, 2026.

What did Balaji Amines report for Q2 FY27?

Balaji Amines reported unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026. Its Board of Directors approved the results on November 2, 2026, after considering the limited review reports issued by statutory auditors M. Anandam & Co., Chartered Accountants.

On a consolidated basis, revenue from operations was ₹4.68 billion in Q2 FY27 and ₹9.33 billion for the first half of FY27. Consolidated profit before tax for the quarter stood at ₹0.89 billion, while profit after tax was ₹0.67 billion. The consolidated numbers include the performance of subsidiary Balaji Speciality Chemicals Limited.

The reported comparison in the company-related results data places Q2 revenue at ₹4.68 billion against ₹3.40 billion a year earlier, a 37.65% increase. The available information attributes the revenue growth to steady volume performance in the company’s core aliphatic amines and speciality chemicals businesses.

How did standalone and consolidated numbers compare?

Balaji Amines posted standalone revenue from operations of ₹4.28 billion in Q2 FY27, while consolidated revenue was higher at ₹4.68 billion. The difference reflects the inclusion of Balaji Speciality Chemicals in the consolidated financial statements.

Standalone profit before tax was ₹0.90 billion during the quarter, and standalone profit after tax was ₹0.69 billion. For the six months ended September 30, 2026, standalone revenue reached ₹8.51 billion, with profit after tax of ₹1.41 billion.

Consolidated profit after tax was marginally below standalone profit after tax at ₹0.67 billion in Q2 FY27. For the first half, consolidated profit after tax was ₹1.46 billion, compared with standalone profit after tax of ₹1.41 billion. The company also released its standalone and consolidated statements of assets and liabilities and cash flows for the half year.

What drove Balaji Amines' revenue growth?

Balaji Amines' reported revenue increase was linked to steady volumes across its aliphatic amines and speciality chemicals segments. These segments were identified as the leading contributors to the company’s Q2 performance, although the released information did not provide segment-wise revenue or profit figures.

The company operates in chemical categories where sales performance can depend on volumes, product mix and operating conditions. In the reported quarter, the top-line result was stronger than the year-ago comparison cited in the results data, with consolidated revenue rising by 37.65% to ₹4.68 billion.

The half-year revenue of ₹9.33 billion provides the broader context for the Q2 result. Balaji Amines had also reported consolidated revenue of ₹4.56 billion for the June 2026 quarter, according to the quarterly data provided. This indicates that the September-quarter revenue remained above the ₹4 billion level, although the company has not provided an outlook in the supplied information.

What regulatory matter did the company disclose?

Balaji Amines disclosed receipt of a Warning-cum-Advisory Letter from the Securities and Exchange Board of India, or SEBI, concerning timely regulatory compliance. The company noted the letter alongside its Q2 FY27 financial results.

The provided information does not specify the underlying compliance matter, any financial penalty, or a further SEBI direction. As a result, the disclosure establishes that management must address the compliance observation but does not support conclusions about the potential financial effect.

For investors, the warning is relevant because listed companies are required to meet disclosure and other regulatory obligations under applicable securities regulations. The company’s results announcement confirms that the matter was formally brought to the attention of the Board and the market.

How does the Q2 result matter for investors and operations?

The Q2 result matters because Balaji Amines recorded a substantial year-on-year increase in consolidated revenue while remaining profitable at both standalone and consolidated levels. Revenue of ₹4.68 billion and consolidated profit after tax of ₹0.67 billion are the key reported indicators for the September 2026 quarter.

The results also show the relevance of Balaji Speciality Chemicals to the group’s reported scale. Consolidated revenue exceeded standalone revenue by about ₹0.40 billion in Q2 FY27, while the first-half consolidated revenue was about ₹0.83 billion above standalone revenue.

Management has scheduled an investor conference call for November 4, 2026, at 4:00 PM IST to discuss the Q2 FY27 results. Analysts and shareholders may look for management commentary on volumes, operating performance, subsidiary contribution and the company’s response to the SEBI advisory.

Conclusion

Balaji Amines delivered Q2 FY27 consolidated revenue of ₹4.68 billion, up 37.65% from the ₹3.40 billion comparison figure, alongside consolidated profit after tax of ₹0.67 billion. The results point to stronger reported revenue performance from the amines and speciality chemicals businesses, with the subsidiary contributing to consolidated scale.

The next disclosed event is the November 4, 2026 investor call, where management is expected to discuss the quarterly financial performance. Investors will also watch for any further disclosure on the SEBI Warning-cum-Advisory Letter and the steps taken to ensure timely regulatory compliance.